Complement is the first line of defense against infections and plays a role in shaping the repertoire of the immune response. However, uncontrolled and excessive complement activation significantly contributes to diverse pathologies ranging from inflammation, autoimmune tissue injury and injury that follows ischemia and reperfusion events. We will use a mesenteric ischemia/reperfusion (IR) model of tissue injury in an attempt to understand the mechanisms of local intestinal damage associated with complement activation and recruitment and activation of neutrophils. Because immunoglobulin deficient, RAG-1-/- mice and complement receptor 2 deficient, Cr2-/- mice, are protected from IR-induced injury and because some Cr2-/- mice have limited numbers of B1 B cells, we asked whether protection of Cr2-/- mice from IR-induced injury could be reversed by normal antibodies. Transfer of normal IgG and IgM into Cr2-/- mice completely restores IR- induced damage with each isotype transferring unique aspects of the damage. Therefore, we hypothesize that certain autoantibodies, produced by Bland B1-like B cells and constituting part of the natural antibody repertoire, recognize cryptic antigens expressed by stressed or injured tissues, activate complement and induce tissue damage. In this proposal, we will test our hypothesis with experiments grouped into three specific aims: 1. To determine the antigenic specificity of IgG natural antibodies that bind to injured tissue and activate complement. 2. To determine the role of CR2 and its ligand in the production of these antibodies. 3. To determine the specific B population that does not produce the damaging antibodies in Cr2- /- mice. These experiments will elucidate the role of complement and antibodies in tissue injury and the mechanism of its activation. During severe injury or organ transplantation, the blood supply to the intestine is decreased causing a condition known as ischemia. When the blood supply is returned (reperfusion), components of the immune system attack the intestine and cause additional damage. This application proposes experiments designed to reveal the components of the immune system that cause the damage. These studies will provide critical data to improve our understanding of ischemia/reperfusion injury that occurs not only in the intestine but will also be applicable to other human conditions such as during heart attacks and strokes.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Bourcier, Katarzyna
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Kansas State University
Schools of Arts and Sciences
United States
Zip Code
Goering, Jeremy; Pope, Michael R; Fleming, Sherry D (2016) TLR2 Regulates Complement-Mediated Inflammation Induced by Blood Loss During Hemorrhage. Shock 45:33-9
Slone, Emily Archer; Pope, Michael R; Fleming, Sherry D (2015) Phospholipid scramblase 1 is required for ?2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation. J Leukoc Biol 98:791-804
Rettig, Trisha A; Harbin, Julie N; Harrington, Adelaide et al. (2015) Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer. Clin Immunol 160:244-54
Pope, Michael R; Fleming, Sherry D (2015) TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation. J Immunol 194:1190-8
Slone, Emily Archer; Fleming, Sherry D (2014) Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury. Clin Immunol 153:228-40
Dib, Lea H; Ortega, M Teresa; Fleming, Sherry D et al. (2014) Bone marrow leptin signaling mediates obesity-associated adipose tissue inflammation in male mice. Endocrinology 155:40-6
Pope, Michael R; Bukovnik, Urska; Tomich, John M et al. (2012) Small ?2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J Immunol 189:5047-56
Tomasi, Maurizio; Hiromasa, Yasuaki; Pope, Michael R et al. (2012) Human ?2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol Immunol 52:207-16
Slone, Emily Archer; Pope, Michael R; Roth, Mary et al. (2012) TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage. Am J Clin Exp Immunol 1:124-135
Shishido, Stephanie N; Varahan, Sriram; Yuan, Kai et al. (2012) Humoral innate immune response and disease. Clin Immunol 144:142-58

Showing the most recent 10 out of 23 publications